SU683616A3 - Способ получени аминоалкилгетероциклических соединений или их солей - Google Patents

Способ получени аминоалкилгетероциклических соединений или их солей

Info

Publication number
SU683616A3
SU683616A3 SU772543651A SU2543651A SU683616A3 SU 683616 A3 SU683616 A3 SU 683616A3 SU 772543651 A SU772543651 A SU 772543651A SU 2543651 A SU2543651 A SU 2543651A SU 683616 A3 SU683616 A3 SU 683616A3
Authority
SU
USSR - Soviet Union
Prior art keywords
salts
preparation
heterocyclic compounds
aminoalkyl
aminoalkyl heterocyclic
Prior art date
Application number
SU772543651A
Other languages
English (en)
Inventor
Ментруп Антон
Шромм Курт
Рент Эрнст-Отто
Рейхл Рихард
Траунэккер Вернер
Хефке Вольфганг
Original Assignee
К.Х.Берингер Зон (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by К.Х.Берингер Зон (Фирма) filed Critical К.Х.Берингер Зон (Фирма)
Application granted granted Critical
Publication of SU683616A3 publication Critical patent/SU683616A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Laminated Bodies (AREA)
  • Nonwoven Fabrics (AREA)
  • Quinoline Compounds (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ
АМИНОАЛКИЛГЕТЕРОЦИКЛИЧЕСКИХ СОЕДИНЕНИЙ ИЛИ ИХ СОЛЕЙ
о или
10
(R - алкил или замещенный алкил) с соединением формулы IV
IV
NH-Z,
с последующим выделением целевого продукта в свободном виде или в виде соли.
Исходные эфиры формулы III получают известными способами.
Пример 1.
CONHj
v
сн,
(O)) о
НО
Смесь из 5 г сложного эфира
COOOijо
лтг
но ) р- снг-та - с - )г-Х
сн.
он
100 мл метанола и 100 мл конц. раствора аммиака слегка нагревают до растворени  реакционной массы, выдерживают при комнатной температуре 12 ч и отдел ют 4,3 г вышеприведенного основани ; т. пл. 198°С. Гидрохлорид т. пл. 235°С.
Аналогично получают соединени , приведенные в таблице.
Таблица
П р одолжение

Claims (1)

1. К. Бюлер, Д. Пирсон. Органические синтезы, М., 1973, ч. 2, с. 390.
SU772543651A 1976-03-09 1977-11-16 Способ получени аминоалкилгетероциклических соединений или их солей SU683616A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (de) 1976-03-09 1976-03-09 Aminoalkylheterocyclen

Publications (1)

Publication Number Publication Date
SU683616A3 true SU683616A3 (ru) 1979-08-30

Family

ID=5971857

Family Applications (4)

Application Number Title Priority Date Filing Date
SU772453505A SU698530A3 (ru) 1976-03-09 1977-02-22 Способ получени аминоалкилгетероциклических соединений или их солей
SU772543651A SU683616A3 (ru) 1976-03-09 1977-11-16 Способ получени аминоалкилгетероциклических соединений или их солей
SU772541704A SU676163A3 (ru) 1976-03-09 1977-11-16 Способ получени аминоалкилгетероциклических соединений или их солей
SU772542149A SU685149A3 (ru) 1976-03-09 1977-11-16 Способ получени аминоалкилгетероциклических соединений или их солей

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU772453505A SU698530A3 (ru) 1976-03-09 1977-02-22 Способ получени аминоалкилгетероциклических соединений или их солей

Family Applications After (2)

Application Number Title Priority Date Filing Date
SU772541704A SU676163A3 (ru) 1976-03-09 1977-11-16 Способ получени аминоалкилгетероциклических соединений или их солей
SU772542149A SU685149A3 (ru) 1976-03-09 1977-11-16 Способ получени аминоалкилгетероциклических соединений или их солей

Country Status (36)

Country Link
US (4) US4154829A (ru)
JP (2) JPS52108970A (ru)
AT (1) AT360542B (ru)
AU (1) AU515953B2 (ru)
BE (1) BE852223A (ru)
BG (4) BG28052A4 (ru)
CA (1) CA1086317A (ru)
CH (8) CH630358A5 (ru)
CS (2) CS209435B2 (ru)
DD (1) DD130037A5 (ru)
DE (1) DE2609645A1 (ru)
DK (1) DK102177A (ru)
ES (10) ES456622A1 (ru)
FI (1) FI69070C (ru)
FR (2) FR2343731A1 (ru)
GB (1) GB1571231A (ru)
GR (1) GR64553B (ru)
HK (1) HK12884A (ru)
HU (1) HU177953B (ru)
IE (1) IE45300B1 (ru)
IL (1) IL51627A (ru)
LU (1) LU76898A1 (ru)
MX (1) MX4878E (ru)
MY (1) MY8500079A (ru)
NL (1) NL7702403A (ru)
NO (1) NO147950C (ru)
NZ (1) NZ183536A (ru)
PH (3) PH16110A (ru)
PL (2) PL112937B1 (ru)
PT (1) PT66282B (ru)
RO (3) RO79706A (ru)
SE (1) SE435059B (ru)
SG (1) SG55583G (ru)
SU (4) SU698530A3 (ru)
YU (1) YU62377A (ru)
ZA (1) ZA771412B (ru)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
FR2455587A1 (fr) 1979-05-04 1980-11-28 Continental Pharma Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (de) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (ru) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
ATE403431T1 (de) * 2001-04-18 2008-08-15 Euro Celtique Sa Benzimidazolon-verbindungen
ATE410165T1 (de) 2001-04-18 2008-10-15 Euro Celtique Sa Nociceptin-analoga
CN1516584A (zh) 2001-04-18 2004-07-28 ŷ�����ǹɷ����޹�˾ 螺吡唑化合物
EP2033644A1 (en) 2001-04-18 2009-03-11 Euro-Celtique S.A. Spiroindene and spiroindane compounds
RU2268883C2 (ru) * 2001-04-18 2006-01-27 Эро-Селтик, С.А. Аналоги ноницептина и фармацевтическая композиция на их основе
RU2265018C2 (ru) * 2001-04-18 2005-11-27 Эро-Селтик, С.А. Производные бензимидазола и фармацевтические композиции на их основе
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
CA2506741A1 (en) * 2002-11-27 2004-06-17 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure
AU2003300297A1 (en) * 2002-12-23 2004-07-22 Artesian Therapeutics, Inc. CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST Beta-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
DE102004001413A1 (de) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
JP2008521805A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス， インコーポレイテッド β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
US20080090827A1 (en) * 2004-11-30 2008-04-17 Artesian Therapeutics, Inc. Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
EP1917253B1 (de) * 2005-08-15 2015-01-07 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1986644A1 (de) * 2006-02-16 2008-11-05 Boehringer Ingelheim International GmbH Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
PE20080142A1 (es) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
JP2010500318A (ja) 2006-08-07 2010-01-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療用医薬組成物
WO2009026227A2 (en) * 2007-08-16 2009-02-26 The University Of Mississippi Highly selective sigma receptor ligands
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 Merck And Co. Substituted benzimidazolones
CH149009A (de) * 1929-08-10 1931-08-15 Chem Ind Basel Verfahren zur Darstellung einer N-substituierten Verbindung der Pyridonreihe.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (ru) * 1961-10-24
FR1516714A (fr) * 1962-11-07 1968-02-05 Bayer Ag Procédé de préparation de dérivés de l'imidazolidine
FR1384708A (fr) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Perfectionnements aux dispositifs de mise en place d'objets
BE659364A (ru) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (ru) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
BG28051A4 (bg) 1980-02-25
ATA122377A (de) 1980-06-15
JPS52108970A (en) 1977-09-12
US4363814A (en) 1982-12-14
NL7702403A (nl) 1977-09-13
PT66282B (pt) 1979-01-17
FI770586A7 (ru) 1977-09-10
IE45300B1 (en) 1982-07-28
ES466605A1 (es) 1978-10-01
IE45300L (en) 1977-09-09
ES456622A1 (es) 1978-03-16
JPS6172A (ja) 1986-01-06
BG27743A3 (bg) 1979-12-12
ES466604A1 (es) 1978-10-01
PH16149A (en) 1983-07-12
MY8500079A (en) 1985-12-31
CH630363A5 (de) 1982-06-15
SU698530A3 (ru) 1979-11-15
FR2372810A1 (fr) 1978-06-30
BG28052A4 (bg) 1980-02-25
PH17635A (en) 1984-10-18
CH630365A5 (de) 1982-06-15
ES466600A1 (es) 1978-10-01
NZ183536A (en) 1981-11-19
ZA771412B (en) 1978-11-29
IL51627A0 (en) 1977-05-31
SE7702609L (sv) 1977-10-11
LU76898A1 (ru) 1978-06-01
CS209435B2 (en) 1981-12-31
PT66282A (pt) 1977-04-01
SG55583G (en) 1984-07-27
US4271158A (en) 1981-06-02
YU62377A (en) 1982-10-31
HK12884A (en) 1984-02-24
CA1086317A (en) 1980-09-23
GB1571231A (en) 1980-07-09
FI69070B (fi) 1985-08-30
CH630359A5 (de) 1982-06-15
HU177953B (en) 1982-02-28
US4154829A (en) 1979-05-15
NO147950B (no) 1983-04-05
RO70569A (ro) 1981-11-24
CH630361A5 (de) 1982-06-15
CH630364A5 (de) 1982-06-15
NO147950C (no) 1983-07-13
CH630362A5 (de) 1982-06-15
US4215119A (en) 1980-07-29
RO79706A (ro) 1982-08-17
ES466598A1 (es) 1978-10-01
PL111240B1 (en) 1980-08-30
ES466602A1 (es) 1978-10-01
CH630358A5 (de) 1982-06-15
AU2300977A (en) 1978-09-14
RO76589A (ro) 1981-04-30
GR64553B (en) 1980-04-14
PH16110A (en) 1983-06-30
FI69070C (fi) 1985-12-10
PL196505A1 (pl) 1979-06-18
FR2343731A1 (fr) 1977-10-07
PL112937B1 (en) 1980-11-29
DK102177A (da) 1977-09-10
NO770804L (no) 1977-09-12
DD130037A5 (de) 1978-03-01
IL51627A (en) 1980-10-26
SE435059B (sv) 1984-09-03
AU515953B2 (en) 1981-05-14
BG28053A4 (bg) 1980-02-25
ES466606A1 (es) 1978-10-01
DE2609645A1 (de) 1977-09-15
FR2372810B1 (ru) 1982-11-26
ES466603A1 (es) 1978-10-01
ES466601A1 (es) 1978-10-01
AT360542B (de) 1981-01-12
FR2343731B1 (ru) 1982-02-26
CS220320B2 (en) 1983-03-25
SU685149A3 (ru) 1979-09-05
MX4878E (es) 1982-11-26
SU676163A3 (ru) 1979-07-25
BE852223A (fr) 1977-09-08
ES466599A1 (es) 1978-10-01
CH630360A5 (de) 1982-06-15

Similar Documents

Publication Publication Date Title
KR840005448A (ko) 티에노〔3, 2-c〕 피리딘 유도체의 제조방법
SU440837A1 (ru)
SU450400A3 (ru) Способ получени аминофениламидина или его соли
US3883543A (en) N-alkyl-1,4-dihydropyridines
US3227724A (en) Process for preparing 2-methyl-3-hydroxypyridines
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
US4148907A (en) Stereoisomers of 1-(1'benzyl-2'pyrryl)-2-di-sec.-butylaminoethanol and pharmaceutical compositions comprising same
JPS55130991A (en) Pyrazole phosphate esters, their preparation and insecticide and acaricide
ES427433A1 (es) Un procedimiento para preparar un compuesto quimico selec- cionado del grupo que consiste en o-tiocarbamato de nitroi- midazolil-etilo.
US4160828A (en) Analgesic phosphinyl compounds and compositions
SU509239A3 (ru) Способ получени -(гетероарил-метил)- 7-дезокси-норморфиновили -норкодеинов
SU510146A3 (ru) Способ получени производныхфенилэтиламина
JPS5432480A (en) Novel preparation of piperidine derivatives
JPS5473758A (en) Asymmetric synthesis of chrysanthemumic acid derivative ester
SU486503A3 (ru) Способ получени производных -фенилжирной кислоты
US3897465A (en) Ethyl beta-(N-methylfurfurylamino) propionate
SU1067005A1 (ru) Способ получени третичных @ -кетофосфиноксидов
SE8003311L (sv) Maleinsyrasalt av 2-fenyl-6-(1-hydroxi-2-t-butyl-aminoetyl-4h-pyrido(3,2-d)-1,3-dioxin
EP0044504A1 (en) A derivative of theonyl thio-propionyl-glycine and process for the preparation thereof
JPS5583786A (en) Diazepine derivative and its preparation
ES412088A1 (es) Procedimiento para preparar compuestos antialergicos.
SU553248A1 (ru) Способ получени 1,3-дигидротиено (3,4-в)индолов
SU488412A3 (ru) Способ получени производных имидазола
JPS55124760A (en) Preparation of 1,4-dihydropyridine derivative or its salt
JPS5547673A (en) Novel pyrone derivative